rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2010-8-17
|
pubmed:abstractText |
This study evaluates the relationship of six polymorphisms found in the CHRNA3, DRD2 and COMT genes with nicotine dependence, the ability to quit smoking and the occurrence of withdrawal symptoms after short-term use of nicotine patch in hospitalized patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1744-8042
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1053-63
|
pubmed:dateRevised |
2011-7-15
|
pubmed:meshHeading |
pubmed-meshheading:20712524-Adolescent,
pubmed-meshheading:20712524-Adult,
pubmed-meshheading:20712524-Aged,
pubmed-meshheading:20712524-Aged, 80 and over,
pubmed-meshheading:20712524-Catechol O-Methyltransferase,
pubmed-meshheading:20712524-Double-Blind Method,
pubmed-meshheading:20712524-Female,
pubmed-meshheading:20712524-Hospitalization,
pubmed-meshheading:20712524-Humans,
pubmed-meshheading:20712524-Male,
pubmed-meshheading:20712524-Middle Aged,
pubmed-meshheading:20712524-Nicotine,
pubmed-meshheading:20712524-Polymorphism, Genetic,
pubmed-meshheading:20712524-Questionnaires,
pubmed-meshheading:20712524-Receptors, Dopamine D2,
pubmed-meshheading:20712524-Receptors, Nicotinic,
pubmed-meshheading:20712524-Smoking Cessation,
pubmed-meshheading:20712524-Substance Withdrawal Syndrome,
pubmed-meshheading:20712524-Tobacco Use Disorder,
pubmed-meshheading:20712524-Transdermal Patch,
pubmed-meshheading:20712524-Treatment Outcome,
pubmed-meshheading:20712524-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
|
pubmed:affiliation |
Department of Basic Medical Sciences, Ghent University, Proeftuinstraat 86, Gent, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|